Skip to main content
. 2020 May 20;20(2):1300–1310. doi: 10.3892/ol.2020.11651

Figure 7.

Figure 7.

Prognostic values of GINS2 in breast cancer. Analysis is demonstrated for (A) All patients (P<1×10−16); (B) ER-positive (P<1×10−16); (C) PR-positive (P=0.00059); (D) HER-2 (P=0.35); (E) Luminal A (P=2.1×10−9); (F) Luminal B (P=0.00038); (G) PR-negative (P=0.21); (H) ER-negative (P=0.094); and (I) Basal-like (P=0.15). HR, hazard ratio; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor 2.